ASPIRIN is a brand name for Aspirin (also known as Acetylsalicylic Acid). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Aspirin has analgesic, antipyretic and anti-inflammatory actions. It is indicated for: - The relief of mild to moderate pain, including headaches, migraine, neuralgia, toothache, sore throat, period pains, aches and pains. - The symptomatic relief of influenza, feverishness, feverish colds - The symptomatic relief of…
Verbatim from this product's MHRA label. Tap a section to expand.
Posology If symptoms persist for more than 3 days, consult your doctor. 6g) daily in divided doses.
Elderly:
Analgesic, antipyretic and anti-inflammatory actions: As for adults. The elderly are more likely to experience gastric side-effects and tinnitus. g. for Kawasaki’s Disease). See Section
Investigations:
Aspirin may interfere with thyroid function test. Side effects are grouped on the basis of System Organ Class. Within each system organ class the frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data) Blood and lymphatic system disorders Common: Increased bleeding tendencies.
Rare:
Thrombocytopenia, agranulocytosis, aplastic anaemia.
Not known:
Cases of bleeding with prolonged bleeding time such as epistaxis, gingival bleeding. Symptoms may persist for a period of 4–8 days after acetylsalicylic acid discontinuation. As a result there may be an increased risk of bleeding during surgical procedures.
Existing (haematemesis, melaena) or occult gastrointestinal bleeding, which may lead to iron deficiency anaemia (more common at higher doses). anaemia, haemolytic anaemia in patients with glucose 6 phosphate dehydrogenase deficiency (G6PD), hypoprothrombinaemia, pancytopenia, occult blood loss, elevated transaminase levels Immune system disorders Rare: Hypersensitivity reactions (bronchospasm, asthma, rhinitis), angio-oedema, allergic oedema, anaphylactic reactions including shock Metabolism and digestive system disorders Not known: Hyperuricemia.
Nervous system disorders Rare:
Intracranial haemorrhage Not known: Headache, vertigo.
Ear and labyrinth disorders Not known:
Reduced hearing ability; tinnitus.
Vascular disorders Rare:
g. for Kawasaki’s disease). - Active peptic ulceration or a past history of peptic ulceration or dyspepsia. - Haemophilia or other haemorrhagic disorder (including thrombocytopenia) coagulopathies or concurrent anticoagulant therapy as there is an increased risk of bleeding.
4 Special warnings and precautions for use: There is a possible association between aspirin and Reye’s syndrome when given to children. Reye’s syndrome is a very rare disease, which affects the brain and liver, and can be fatal. g. for Kawasaki’s disease).
Aspirin should be used with caution in patients with: • Acetylsalicylic acid may promote bronchospasm and asthma attacks or other hypersensitivity reactions. Risk factors are existing asthma, hay fever, nasal polyps or chronic respiratory diseases.
g. with skin reactions, itching or urticaria). g. tooth extraction). Use with caution before surgery, including tooth extraction. Temporary discontinuation of treatment may be necessary. 2). Where prolonged therapy is required, patients should be reviewed regularly.
• Before commencing long-term aspirin therapy for the management of cardiovascular or cerebrovascular disease patients should consult their doctor who can advise on the relative benefits versus the risks for the individual patient.
5). • Acetylsalicylic acid is not recommended during menorrhagia where it may increase menstrual bleeding. • Acetylsalicylic acid is to be used with caution in cases of hypertension and when patients have a past history of gastric or duodenal ulcer or haemorrhagic episodes or are undergoing therapy with anticoagulants • Patients should report any unusual bleeding symptoms to their physician.
8). Acetylsalicylic acid should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. e. 5). If the combination cannot be avoided, close observation for signs of bleeding is recommended.
g. for Kawasaki’s disease). - Active peptic ulceration or a past history of peptic ulceration or dyspepsia. - Haemophilia or other haemorrhagic disorder (including thrombocytopenia) coagulopathies or concurrent anticoagulant therapy as there is an increased risk of bleeding.
5) - Severe cardiac failure
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Aspirin in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Haemorrhagic vasculitis.
Respiratory, thoracic and mediastinal disorders Uncommon:
Rhinitis, dyspnoea.
Rare:
Bronchospasm, asthma attacks.
Reproductive system and mammary disorders Rare:
Menorrhagia Gastrointestinal disorders Common: Dyspepsia.
Rare:
Severe gastrointestinal haemorrhage, nausea, vomiting.
Not known:
Gastric or duodenal ulcers and perforation which can occasionally be major (may develop bloody or black tarry stools, severe stomach pain and vomiting blood), gastrointestinal irritation (mild stomach pain), erosions, gastritis, heartburn, Fatalities have occurred.
Hepatobiliary disorders Not known:
Hepatic insufficiency, hepatitis (particularly in patients with SLE or connective tissue disease) Skin and subcutaneous tissue disorders Uncommon: Urticaria.
Rare:
Steven-Johnsons syndrome, Lyells syndrome, purpura, erythema nodosum, erythema multiforme Renal and urinary tract disorders Not known: Impaired renal function, Urate kidney stones Body as a whole – general disorders Not known: Salicylism – (mild chronic salicylate intoxication may occur after repeated administration of large doses, symptoms include dizziness, tinnitus, deafness, sweating, nausea, vomiting, headache and mental confusion, and may be controlled by reducing the dose) Children Aspirin may be associated with the development of Reye's Syndrome (encephalopathy and hepatic failure) in children presenting with an acute febrile illness.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows the continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
5) • Acetylsalicylic acid in low doses reduces uric acid excretion. 5) • Where analgesics are used long-term (>3 months) with administration every two days or more frequently, headache may develop or worsen. Headache induced by overuse of analgesics (MOH medication-overuse headache) should not be treated by dose increase.
In such cases, the use of analgesics should be discontinued in consultation with the doctor. • The elderly may be more susceptible to the toxic effects of NSAIDs, including salicylates. Continuous, prolonged use of aspirin should be avoided in the elderly because of the risk of gastrointestinal bleeding and perforation.
Salicylates should be used with caution in patients with a history of coagulation abnormalities. They may also induce gastro- intestinal haemorrhage, occasionally major. • Aspirin should not be taken by patients with a stomach ulcer or history of stomach ulcers.
5). • Aspirin should be used with caution in patients with moderately impaired renal or hepatic function (avoid if severe), or in patients who are dehydrated since the use of NSAIDs may result in deterioration of renal function. Liver function tests should be performed […]